CRT 2017 : Japan FDA - Using Real-World Evidence to Support Marketing, Post-Marketing Safety Measures and Regulatory Decisions

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

Japan FDA - Using Real-World Evidence to Support Marketing, Post-Marketing Safety Measures and Regulatory Decisions

Featuring

  • Mitchell Krucoff
  • Hiroyoshi Yokoi
  • Pablo Morales
  • Jenny Andersen
  • Akihide Konishi

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Methods to Gather and Analyze RWE – US Academia - Mitchell Krucoff
Current Methodology and Future Horizons – Japanese Academia - Hiroyoshi Yokoi
Regulatory Perspectives on RWE – US Regulatory View - Pablo Morales
Issues and Current Experience Using RWE to Support Regulatory Applications – US Industry - Jenny Andersen
Using Post-Marketing Surveillance for Safety Measure – Japanese Regulatory View - Akihide Konishi

Target Audience

Learning Objectives

Related Moments

No Racial Disparities in the Treatment of ST Elevation Myocardial Infarction - A Community-based Experience
Journal
Article on No Racial Disparities in the Treatment of ST Elevation Myocardial Infarction - A Community-based Experience
CVC 2016 Arterial - Critical Limb Ischemia/Limb Salvage/Wound Care II.
Conference
A session on Critical Limb Ischemia/Limb Salvage/Wound Care II from CVC 2016
Managing Heart Failure Patients with Multivessel Disease – Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention
Journal
Article on Managing Heart Failure Patients with Multivessel Disease – Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention
Loading Simple Education